Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (341-350 of 487) with videos related to

Pageof 49
Sort By:
Journal for Immunotherapy of Cancer|April 14, 2021
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersRivka R Colen, Christian Rolfo, Murat Ak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation TrialVivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.
JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
Cancer|March 7, 2023
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumorsFilip Janku, Milind M Javle, Shiraj Sen, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Author response to Cunha <i>et al</i>Rivka R Colen, Christian Rolfo, Murat Ak, et al.
JCO Precision Oncology|July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced CancersMohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> <sup>V600</sup>-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.
Blood|September 15, 2022
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemiaRobert J Kreitman, Philippe Moreau, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2018
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse CancersVivek Subbiah, Ravi Murthy, David S Hong, et al.
Journal of Medical Internet Research|March 15, 2019
Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational StudyGoldy C George, Eucharia C Iwuanyanwu, Adrianna S Buford, et al.
Pageof 49

Showing results (341-350 of 487) with videos related to

Sort By:
Pageof 49
Journal for Immunotherapy of Cancer|April 14, 2021
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersRivka R Colen, Christian Rolfo, Murat Ak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation TrialVivek Subbiah, Pete M Anderson, Kalevi Kairemo, et al.
JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
Cancer|March 7, 2023
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumorsFilip Janku, Milind M Javle, Shiraj Sen, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Author response to Cunha <i>et al</i>Rivka R Colen, Christian Rolfo, Murat Ak, et al.
JCO Precision Oncology|July 14, 2022
Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced CancersMohamed A Gouda, Helen J Huang, Sarina A Piha-Paul, et al.
Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> <sup>V600</sup>-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.
Blood|September 15, 2022
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemiaRobert J Kreitman, Philippe Moreau, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2018
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse CancersVivek Subbiah, Ravi Murthy, David S Hong, et al.
Journal of Medical Internet Research|March 15, 2019
Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational StudyGoldy C George, Eucharia C Iwuanyanwu, Adrianna S Buford, et al.
Pageof 49